February 2012

Volume 67

Issue 2

Impact factor: 6.525

Thorax is one of the world's leading respiratory medicine journals, publishing clinical and experimental research articles on respiratory medicine, paediatrics, immunology, pharmacology, pathology, and surgery. Thorax is one of the highest ISI ranked journals covering all aspects of pulmonary medicine. Each issue covers topics such as COPD, asthma, smoking, respiratory infection and lung cancer.

Free: Editor's choice

Nursing-home-acquired pneumonia in Germany: an 8-year prospective multicentre study

The epidemiology of community-acquired pneumonia (CAP) has undergone significant changes in the past few decades. Patients with CAP present at an increasingly older age and with severe disabilities. Mortality in these patients is usually high, reaching up to...
Read this free article chosen by the editor >>
Previous choices >>

Airwaves now free!

For a quick overview of the top articles in this month's issue, take a look at Airwaves written by the Thorax Editors.

Read the latest Airwaves now for free >>

Hot topic: cystic fibrosis

This month Thorax looks at cystic fibrosis with the following paper:
Results of a phase IIa study of VX-809, an investigational CFTR corrector compound, in subjects with cystic fibrosis homozygous for the F508del-CFTR mutation >>

In the news

Nocturnal temperature controlled laminar airflow for treating atopic asthma: a randomised controlled trial

In patients with atopic asthma, the abnormal immune response to inhalant allergens is an important contributor to symptoms. Studies undertaken...
Read this article >>

BTS Guidelines

Click here to view all the latest BTS guidelines published in Thorax, and the latest BTS abstract book

Click here for more information >>

Podcasts

Listen to the latest podcast from Thorax:

Journal club: Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis >>
Previous podcasts from Thorax >>